Cargando…
Lost in translation: barriers to implementing clinical immunotherapeutics for autoimmunity
Induction of selective, autoantigen-specific tolerance is the “holy grail” for the treatment and prevention of autoimmune diseases. Despite successes in many differential murine models, rational and efficient translation to the clinic has been difficult. During the 5th Annual Federation of Clinical...
| Autores principales: | , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
The Rockefeller University Press
2005
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2213225/ https://www.ncbi.nlm.nih.gov/pubmed/16275758 http://dx.doi.org/10.1084/jem.20051224 |